Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion NYT | Top Stories By: Rebecca Robbins 31 March 2026 at 22:49 Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug. © Scott Olson/Getty ImagesEli Lilly’s headquarters in Indianapolis. The company, which is flush with cash from sales of its weight-loss drug, has been on a deal-making spree.
Ozempic Is About to Go Generic in India, China and Canada NYT | China By: Rebecca Robbins， Meaghan Tobin， Eshe Nelson， Alex Travelli and Pragati K.B. 19 March 2026 at 12:00 In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
Login
